biomedicina slovenica


pr=Castiglione : 33

  1. Gruber G; Cole BF; Castiglione-Gertsch M; Holmberg SB; Lindtner J; Golouh R; Collins J; Crivellari D; Thurlimann B; Simoncini E; Fey MF; Gelber RD; Coates AS; Price KN; Goldhirsch A; Viale G; Gusterson BA; Eržen D; Čufer T; Majdič E; Štabuc B; Lamovec J; Jančar J; Vrhovec I; Kramberger M; Novak J; Naglas M; Senčar M; Červek J; Šebek S; Cerar O; Plesničar A; Zakotnik B
    Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
    2008
  2. Thurlimann Beat; Price Karen N; Gelber Richard D; Holmberg Stig B; Crivellari Diana; Colleoni Marco; Collins John; Forbes John F; Castiglione-Gertsch Monica; Lindtner J; Eržen D; Čufer T; Červek J; Cerar O; Zakotnik B; Majdič E; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93
    2009
  3. Pagani O; Gelber S; Simoncini E; Castiglione-Gertsch M; Price KN; Gelber RD; Holmberg SB; Crivellari D; Lindtner J; Čufer T
    Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93
    2009
  4. Colleoni M; Li SZ; Gelber Richard D; Coates Alan S; Castiglione-Gertsch M; Price Karen; Lindtner Jurij; Rudenstam Carl-Magnus; Crivellari Diana; Collins Joseph; Pagani Olivia; Simoncini E.; Thürlimann Beat; Murray Elizabeth; Forbes John Alexander; Eržen Darja; Holmberg Stig B.; Veronesi A.; Goldhirsch Aron; Plesničar Andrej; Majdič Elga; Štabuc Borut; Golouh Rastko; Lamovec Janez; Jančar Janez; Vrhovec Ivan; Kramberger Marta; Novak Janez; Naglas M; Senčar Mojca; Červek Jožica; Šebek Slava; Cerar Olga; Čufer Tanja
    Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer
    2005
  5. Gruber Guenther; Bonetti Marco; Nasi Laura M; Price Karen; Castiglione-Gertsch Monica; Rudenstam Carl-Magnus; Holmberg Stig B; Lindtner Jurij; Golouh Rastko; Collins John
    Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from international breast cancer study group trial VI
    2005
  6. Gruber G; Bonetti M; Nasi M; Price K; Castiglione-Gertsch M; Rudenstam C; Holmberg S; Lindtner J; Golouh R; Collins J
    Extracapsular tumor spread (ECS) in premenopausal node-positive breast cancer patients treated with classical CMF: long-term results from IBCSG trial VI
    2004
  7. Trihia Helen; Murray Susan; Price Karen; Gelber Richard D; Golouh Rastko; Goldhirsch Aron; Coates Alan S; Collins John; Castiglione-Gertsch Monica; Gusterson Barry A
    Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors - a surrogate marker?
    2003
  8. Aebi S; Gelber S; Castiglione-Gertsch M; Gelber RD; Collins J; Thurlimann B; Rudenstam CM; Lindtner J
    Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
    2000
  9. Colleoni M; Litman HJ; Castiglione-Gertsch M; Sauerbrei W; Gelber RD; Bonetti M; Coates AS; Schumacher M; Bastert G; Lindtner J
    Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF
    2002
  10. Wallgren A; Bonetti M; Gelber RD; Goldhirsch A; Castiglione-Gertsch M; Holmberg SB; Lindtner J
    Risk factors for locoregional recurrence among breast cancer patients: results from International breast cancer study group trials I through VII
    2003
  11. Crivellari Diana; Price Karren; Gelber Richard D; Castiglione-Gertsch Monika; Rudenstam Carl-Magnus; Lindtner Jurij
    Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International breast cancer study group trial IV
    2003
  12. Colleoni M; Zahrieh D; Nole F; Gelber RD; Castiglione-Holmberg M; Price KN; Thurlimann B; Lindtner J; Forbes J; Collins J
    Is medial breast cancer without axillary node involvement really node-negative?
    2002
  13. Castiglione-Gertch M; O'Neill A; Gelber RD; Nasi ML; Rabaglio M; Lindtner J; Crivellari D; Forbes J; Fey M; Perey L
    Is the addition of adjuvant chemotherapy always necessary in node negative (N-) pre/perimenopausal breast cancer patients (pts) who recive goserelin?
    2002
  14. Colleoni Marco; Gelber Shari; Coates Alan S; Castiglione-Gertsch Monica; Gelber Richard D; Price Karen; Rudenstam Carl-Magnus; Lindtner Jurij; Collins John; Thuerlimann Beat
    Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
    2001
  15. Thuerlimann B; Price KN; Castiglione M; Lindtner J; Eržen D; Čufer T; Červek J; Cerar O; Zakotnik B; Majdič E; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International breast cancer study group trial 11-93
    2001
  16. Gelber Shari; Coates Alan A; Goldhirsch Aron; Castiglione-Gertsch Monica; Marini Gianluigi; Lindtner Jurij; Edelmann David Z; Gudgeon Anne; Harvey Vernon; Gelber Richard D
    Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer
    2001
  17. Castiglione-Gertsch M; Price KN; Nasi ML; Lindtner J; Eržen D; Crivellari D; Veronesi A; Fey M; Pagani O; Collins J
    Is the addition of adjuvant chemotherapy always necessary in node negative (N-) postmenopausal breast cancer patients (Pts) who receive tamoxifen (TAM)?: first results of IBCSG trial IX
    2000
  18. Colleoni Marco; Smith Heather; Castiglione-Gertsch Monica; Gelber Richard D; Sauerbrei Willi; Coates Alan S; Schumacher Martin; Bonetti Marco; Bastert Gunter; Lindtner Jurij
    Duration of adjuvant chemotherapy: a joint analysis of two randomized trails investigating 3 versus 6 courses of cyclophosphamide methotrexate and 5-fluorouracil (CMF) without endocrine treatment
    2000
  19. Colleoni Marco; O'Neill Anne; Goldhirsch Aron; Gelber Richard D; Bonetti Marco; Thuerlimann Beat; Price Karen N; Castiglione-Gertsch Monica; Coates Alan S; Lindtner Jurij
    Identifying breast cancer patients at high risk for bone metastases
    2000
  20. Colleoni Marco; Bonetti Marco; Coates Alan S; Castiglione-Gertsch Monica; Gelber Richard D; Price Karen; Rudenstam Carl-Magnus; Lindtner Jurij; Collins John; Thuerlimann Beat
    Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors
    2000
  21. Crivellari Diana; Bonetti Marco; Castiglione-Gertsch Monica; Gelber Richard D; Rudenstam Carl-Magnus; Thuerlimann Beat; Price Karen N; Coates Alan S; Huerny Christoph; Lindtner Jurij
    Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International breast cancer study group Trial VII
    2000
  22. Hurny Christoph; Bernhard Juerg; Coates Alan; Peterson Harriet F; Castiglione-Gertsch Monica; Gelber Richard D; Rudenstam Carl-Magnus; Collins John; Lindtner Jurij; Goldhirsch Aron; Senn Hans-Joerg
    Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an International adjuvant breast cancer trial
    1996
  23. Colleoni M; Price K; Gelber RD; Castiglione-Gertsch M; Rudenstam CM; Coates A; Thuerlimann B; Lindtner J; Collins J; Goldhirsch A
    Dose-response effect of adjuvant cyclophosphamide, methotrexate, fluorouracil in node-positive breast cancer
    1998
  24. Pagani O; O'Neil A; Castiglione M; Gelber RD; Goldhirsch A; Rudenstam C-M; Lindtner J; Collins J; Crivellari D; Coates A
    Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer pateints with axillary node involvement: results of the International breast cancer study group (IBCSG) trial VI
    1998
  25. Goldhirsch A; Gelber RD; Castiglione M; O'Neill A; Thurlimann B; Rudenstam C-M; Lindtner J; Collins J; Forbes J; Crivellari D
    Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International breast cancer study group (IBCSG) trial VI
    1997
  26. Stucchi-Goldhirsch E; Forbes J; Price KN; Castiglione M; Gelber RD; Rudenstam C-M; Lindtner J; Collins J; Cavalli F; Cortes-Funes H
    Low-dose prednisone (p) in combination with adjuvant systemic therapy (AST) for operable breast cancer (BC) is associated with increased risk of second (non-breast) malignancies.
    1994
  27. Marini G; Murray S; Goldhirsch A; Gelber RD; Castiglione-Gertsch M; Price KN; Tattersall MHN; Rudenstam C-M; Collins J; Lindtner J
    The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurence of second malignancies in patients with breast cancer
    1996
  28. Goldhirsch A; Gelber RD; Forbes J; Price K; Castiglione M; Rudenstam C-M; Lindtner J; Hacking A; Senn H
    Timing breast cancer surgery
    1991
  29. Crivellari D; Price KN; Hagen M; Goldhirsch A; Gelber RD; Castiglione M; Coates AS; Rudenstam C-M; Collins J; Lindtner J
    Routine tests during follow-up of patients after primary treatment for operable breast cancer
    1995
  30. Goldhirsch Aron; Gelber Richard D; Castiglione Monica; Price Karen N; Rudenstam Carl-Magnus; Lindtner J; Collins John; Senn Hans-Jorg; Brunner Kurt W; Gallioni Enzo
    Present and future projects of the International breast cancer study group
    1994
  31. Goldhirsch A; Gelber RD; Price KN; Castiglione M; Coates AS; Rudenstam C-M; Collins J; Lindtner J; Hacking A; Marini G
    Effect of systemic adjuvant treatment on first sites of breast cancer relapse
    1994
  32. Spataro V; Price K; Goldhirsch A; Cavalli F; Simoncini E; Castiglione M; Rudenstam CM; Collins J; Lindtner J; Gelber RD
    Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance
    1992
  33. Castiglione M; Gelber RD; Goldhirsch A; Lindtner J; Novak J; Naglas M; Červek J; Cerar O; Golouh R; Lamovec J; Jančar J; Šebek S
    Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality
    1990


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics